ClinicalTrials.Veeva

Menu

The Effects of Premeal Consumption of Protein-enriched Bar on Blood Glucose Level and Secretion of Hormones

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Other: breakfast follows by protein bar
Dietary Supplement: premeal protein-enriched bar intake

Study type

Interventional

Funder types

Other

Identifiers

NCT02589028
H-1504-103-666

Details and patient eligibility

About

The aim of this study is to explore premeal protein-enriched bar effect in postprandial glucose levels and concentration of plasma incretin hormones [glucagon-like peptide 1 (GLP-1) and/or glucose-dependent insulinotropic polypeptide (GIP)] in healthy subjects and those with type 2 diabetes.

Full description

Fifteen healthy subjects and fifteen subjects with type 2 diabetes treated by diet and/or metformin, SU, DPP4 inhibitors will be recruited. Every subject will studied on 2 separate days in random order with 1-2 week intervals. These participants will consume protein enriched bar followed by a standardized high-glycemic-index breakfast in a hospital setting or breakfast followed protein enriched bar in a cross-over fashion. Blood sampling will be done at the moment of start of breakfast (0 min) and then 10, 20, 30, 60, 90, 120, 150, 180 min. Plasma glucose levels, total/active GLP-1, GIP, insulin, C-peptide, glucagon will be measured. Incremental area under the curve (iAUC) of glucose level and hormone from 0 min to 180 min will be calculated.

Enrollment

30 patients

Sex

All

Ages

19 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BMI 18.5~35 kg/m2

  • Healthy volunteer:

    • never diagnosed by diabetes and
    • fasting plasma glucose <=100mg/dl and HbA1c <6.0%
  • participants with diabetes

    • diagnosed by diabetes
    • if treated by diet, HbA1c 6.0~9.0%
    • if treated by metformin or SU, HbA1c 6.0~10.0%
    • if treated by DPP4 inhibitor HbA1c 6.0~9.0%

Exclusion criteria

  • Those who diagnosed by Type 1 diabetes
  • History of DKA
  • History of insulin therapy
  • Allergy to wheat, flour, nuts, milk
  • Pregnancy/lactation
  • AST or ALT >2.5 times of upper normal reference range
  • eGFR <30 mL/min/1.73m2
  • Hb <10g/dl
  • History of GI surgery (except hemorrhoidectomy, appendectomy)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

30 participants in 2 patient groups

premeal protein bar first
Experimental group
Description:
intervention: premeal protein-enriched bar intake * protein enriched bar(total serving: 30g, 43.28% carbohydrate; 1.29% fat; 40.39% protein; 42.63% fiber) will be given 30 minutes before breakfast * protein enriched bar is provided with 150 ml of water * amount of protein bar : 30g * breakfast : plain bagel, cream cheese, strawberry jam, orange juice 210ml
Treatment:
Dietary Supplement: premeal protein-enriched bar intake
breakfast first
Other group
Description:
intervention: breakfast follows by protein bar * protein enriched bar is provided with 150 ml of water shortly after breakfast * amount of protein bar : 30g * breakfast : plain bagel, cream cheese, strawberry jam, orange juice 210ml
Treatment:
Other: breakfast follows by protein bar

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems